HALO logo
halo search icon
Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
CRNX · NAS

Crinetics Pharmaceuticals Inc

US$36.27

Price Arrow1.33 (3.81%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusEMA 125 BreakdownFakey Shakey - LongFakey Shakey - Long (Realtime)HALO AllHALO Consensus Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Crinetics Pharmaceuticals Inc Overview

CRNX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Neutral

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About CRNX

icon

Telephone

1.858.450.6464

icon

Address

6055 Lusk Boulevard, San Diego, CA 92121

Description

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. The firm is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

CRNX Price Chart

Key Stats

Market Cap

US$3.68B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 25.83 - 57.99

Trade Value (12mth)

US$12,205,304.00

1 week

-4.98%

1 month

-10.18%

YTD

-25.23%

1 year

16.66%

All time high

62.53

Key Fundamentals

EPS 3 yr Growth

56.90%

EBITDA Margin

NaN%

Operating Cashflow

-$378m

Free Cash Flow Return

-31.40%

ROIC

-38.70%

Interest Coverage

0.00

Quick Ratio

12.30

Other Data

Shares Outstanding (Fully Diluted)

104m

HALO Sector

Healthcare

Next Company Report Date

04-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CRNX Announcements

Latest Announcements

DateAnnouncements
08 May 26
08 May 26
08 May 26
08 May 26
08 May 26

CRNX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-3.69-3.69-4.95locklocklock
EPS (Fully Diluted)
$locklocklocklock-3.69-3.69-4.95locklocklock
Growth
%locklocklocklock-17.1N/A-33.9locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Crinetics Pharmaceuticals Inc (CRNX:NAS)?
Halo FAQ
The current share price of Crinetics Pharmaceuticals Inc (CRNX:NAS) is USD$36.27.
What is the 52-week high share price for Crinetics Pharmaceuticals Inc (CRNX:NAS)?
Halo FAQ
The 52-week high share price for Crinetics Pharmaceuticals Inc (CRNX:NAS) is USD$57.99.
What is the 52-week low share price for Crinetics Pharmaceuticals Inc (CRNX:NAS)?
Halo FAQ
The 52-week low share price for Crinetics Pharmaceuticals Inc (CRNX:NAS) is USD$25.83.
What is the dividend yield for Crinetics Pharmaceuticals Inc (CRNX:NAS)?
Halo FAQ
Crinetics Pharmaceuticals Inc (CRNX:NAS) does not pay a dividend.
What was Crinetics Pharmaceuticals Inc (CRNX:NAS) last dividend payment?
Halo FAQ
Crinetics Pharmaceuticals Inc (CRNX:NAS) does not pay a dividend.
What is the franking level for Crinetics Pharmaceuticals Inc (CRNX:NAS)?
Halo FAQ
Crinetics Pharmaceuticals Inc (CRNX:NAS) has a franking level of 0.00%.
In which sector is Crinetics Pharmaceuticals Inc (CRNX:NAS) classified?
Halo FAQ
Crinetics Pharmaceuticals Inc (CRNX:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.